(Press-News.org) Multigene testing of women negative for BRCA1 and BRCA2 found some of them harbored other harmful genetic mutations, most commonly moderate-risk breast and ovarian cancer genes and Lynch syndrome genes, which increase ovarian cancer risk, according to an article published online by JAMA Oncology.
Multigene panel genetic tests are increasingly recommended for patients evaluated for a predisposition to hereditary breast/ovarian cancer (HBOC). However, the rapid introduction of these tests has raised concerns because many of the tested genes are low- to moderate-risk genes for which consensus management guidelines have not been introduced or were introduced only very recently, according to the study background.
Leif W. Ellisen, M.D., Ph.D., of Massachusetts General Hospital Cancer Center, Boston, and coauthors wanted to determine how often multigene panel testing would identify mutations that warranted some clinical action among women appropriately tested but lacking BRCA1 and BRCA2 mutations.
The authors enrolled 1,046 women and carried out multigene panel testing on all the participants. Among the 1,046 women, 3.8 percent of them (40 women) who were negative for BRCA1 and BRCA2 had harmful mutations in other moderate-risk genes.
The authors included an additional 23 patients in the study's clinical management analysis and results indicate that among 63 women positive for mutations, the majority of them (33 women [52 percent]) would be considered for additional disease-specific screening and/or prevention measures beyond those based on personal and family history alone. Additional family testing also would be considered for first-degree relatives, according to the results. In the large majority of mutation-positive cases (58 of 63 [92 percent]), personal and/or family histories included cancer associated with the mutant genes.
"Multigene panel testing for patients with suspected HBOC risk identifies substantially more individuals with relevant cancer risk gene mutations than does BRCA1/2 testing alone. Identifying such mutations is likely to change management for the majority of these individuals and their families in the near term, and in the long term should lead to development of effective management guidelines and improved outcomes for at-risk individuals," the study concludes.
INFORMATION:
(JAMA Oncol. Published online August 13, 2015. doi:10.1001/jamaoncol.2015.2690. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Authors made conflict of interest disclosures. This study was funded by unrestricted philanthropic gifts from the MGH Friends Fighting Breast Cancer and the Tracey Davis Memorial Fund and by the Breast Cancer Research Foundation. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Commentary: Usefulness of Multigene Testing
In a related commentary, Elizabeth M. Swisher, M.D, of the University of Washington Medical Center, Seattle, writes: "I applaud Desmond et al for tackling this important and challenging question. Multigene testing is rapidly becoming the norm for genetic cancer risk assessment. We must continue to assess the effect of such testing on clinical care and patient experience and work to provide meaningful guidelines for cancer-preventive care for those with less common genetic findings."
(JAMA Oncol. Published online August 13, 2015. doi:10.1001/jamaoncol.2015.2699. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: The author is supported by the Ovarian Cancer Research Fund, the Wendy Feuer Fund for the Prevention and Treatment of Ovarian Cancer and a grant from the Department of Defense Ovarian Cancer Research Program. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Media Advisory: To contact corresponding author Leif W. Ellisen, M.D., Ph.D., call Katie Marquedant at 617-726-0337 or email kmarquedant@mgh.harvard.edu. To contact corresponding commentary author Elizabeth M. Swisher, M.D., call McKenna Princing at 206-221-9394 or email McKennaP@uw.edu.
To place an electronic embedded link in your story: Links will be live at the embargo time: http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.2690
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.2699
A study by researchers at three academic medical centers has shown that screening women with a suspected risk of hereditary breast or ovarian cancer for risk-associated genes other than BRCA1 and 2 provides information that can change clinical recommendations for patients and their family members. The report from a team led by a Massachusetts General Hospital (MGH) Cancer Center investigator is being published in the August issue of JAMA Oncology.
"The traditional approach has been to test most women with suspected hereditary risk for breast and/or ovarian cancer for ...
A University of Manchester study which followed up 38,415 people admitted to hospital with self-harm has, for the first time, investigated the association between the treatment patients receive in hospital and their subsequent risk of death.
Published in the Lancet Psychiatry, the study looked at adults who had self-harmed and attended five hospital emergency departments in Manchester, Oxford and Derby between 2000 and 2010. The researchers found that within 12 months, 261 had died by suicide and a further 832 had died from other causes.
The study also examined the ...
Organ transplant recipients are twice as likely to develop melanoma as people who do not undergo a transplant, and three times more likely to die of the dangerous skin cancer, suggests new research led by a Johns Hopkins Bloomberg School of Public Health student.
The findings, reported Aug. 13 in the Journal of Investigative Dermatology, suggest that the immunosuppressive medications that transplant recipients receive to keep them from rejecting their new organs -- especially the high doses administered at the time of transplant -- may make them more susceptible to later ...
A study on granting local sales people pricing discretion shows that profits improve by up to 11% when local sales forces are empowered to negotiate with customers. However a centralized system that uses optimization techniques and limits local sales discretion improves profits still further, by an additional 20%. The research appears in the current issue of Management Science, a publication of the Institute for Operations Research and the Management Sciences (INFORMS), the leading professional association in analytics and operations research.
"This hybrid approach balances ...
Summary: Children born with the major congenital heart defect hypoplastic left heart syndrome (HLHS) often must undergo a series of corrective surgeries beginning at birth. While most have the standard three-stage Norwood procedure, a hybrid strategy has been introduced to offset some disadvantages associated with the Norwood surgeries. In a report in The Journal of Thoracic and Cardiovascular Surgery, investigators compare whether outcomes can be improved if an arterial shunt is used as a source of pulmonary blood flow rather than the more conventional venous shunt as ...
For smokers, the number of cigarettes smoked per day and current body mass index are predictive of changes in weight after quitting smoking, according to researchers at Penn State College of Medicine.
Quitting smoking may lead to some weight gain but how much weight gain depends on the individual. Previous research shows that for some it can be just a few pounds, but for others it can be more than 25 pounds. Unfortunately, factors that can help predict the amount of weight a smoker may gain are not well understood.
"Many smokers are concerned about gaining weight after ...
PHOENIX -- A multicenter study involving Mayo Clinic researchers has found that the National Cancer Institute's Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), was accurate, reliable and responsive, compared to other, established patient-reported and clinical measures. The study is published today in the journal JAMA Oncology.
"In most cancer clinical trials, information on side effects is collected by providers who have limited time with their patients and current patient questionnaires are limited in scope and depth," ...
Early humans were the dominant cause of the extinction of a variety of species of giant beasts, new research has revealed.
Scientists at the universities of Exeter and Cambridge claim their research settles a prolonged debate over whether mankind or climate change was the dominant cause of the demise of massive creatures in the time of the sabretooth tiger, the woolly mammoth, the woolly rhino and the giant armadillo.
Known collectively as megafauna, most of the largest mammals ever to roam the earth were wiped out over the last 80,000 years, and were all extinct by ...
The discovery of antidepressant drugs in the 1950s led to the first biochemical hypothesis of depression, known as the monoamine hypothesis. This hypothesis proposes that an imbalance of certain brain chemicals is the key cause of depression. Research has investigated whether and to what degree the "reward and pleasure" chemical dopamine and, more recently, the "happiness" chemical serotonin, could be the neurotransmitters involved in the malady. However, the monoamine hypothesis does not seem to fully explain the complexity of human depression. Now a new study offers one ...
August 13, 2015--A visit to the dentist has the potential to be more than a checkup of our teeth as patients are increasingly screened for medical conditions like heart disease and diabetes. A new study by researchers at Columbia University's Mailman School of Public Health focuses on dental screenings for drug misuse, finding 77 percent of dentists ask patients about illicit drug use, and 54 percent of dentists believe that such screenings should be their responsibility. Results of the study are online in the journal Addiction.
"There are a sizeable number of people ...
